# OnCo record zgdh3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/zgdh3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "zgdh3", "NCT02645981" ;
  schema:name "ZGDH3 (donafenib vs sorafenib)"@en ;
  schema:description "The first trial in which a new pill beat sorafenib on survival in liver cancer, with a Chinese deuterated redesign of sorafenib itself."@en ;
  schema:url <https://onco.cc/trials/zgdh3/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02645981>, <https://doi.org/10.1200/JCO.20.02672> ;
  onco:status "positive" ;
  onco:tag "china" ;
  onco:phase "2/3" ;
  schema:startDate "2016-03" ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/donafenib/>, <https://onco.cc/drugs/sorafenib/> ;
  onco:companies <https://onco.cc/companies/zelgen/> ;
  onco:people <https://onco.cc/people/qin-shukui/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-gordan-j-clin-oncol/> .